John L. Knopf is CEO & President at ACCELERON PHARMA INC (XLRN). They have made 9 open-market trades across 1 company since 2014, most recently 2016-11-09.
CIK 0001280600
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XLRN | 245,627 | $43.9M |
Shares reported on the most recent Form 4, priced at the 2016-11-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLRN | SELL | 2016-11-09 | 2016-11-14 | $32.19 | $3.2M | -5.3% | -28.1% | -35.6% |
| XLRN | SELL | 2016-07-06 | 2016-07-06 | $33.75 | $1.4M | -6.1% | -4.7% | +2.1% |
| XLRN | SELL | 2016-07-05 | 2016-07-06 | $33.26 | $1.0M | -6.1% | -4.7% | +2.1% |
| XLRN | SELL | 2016-07-01 | 2016-07-06 | $34.72 | $973K | -6.1% | -4.7% | +2.1% |
| XLRN | SELL | 2016-07-01 | 2016-07-06 | $33.87 | $3.4M | -6.1% | -4.7% | +2.1% |
| XLRN | SELL | 2016-05-20 | 2016-05-20 | $33.17 | $855K | +10.4% | +3.4% | -11.1% |
| XLRN | SELL | 2016-05-19 | 2016-05-20 | $33.04 | $1.2M | +10.4% | +3.4% | -11.1% |
| XLRN | SELL | 2016-05-18 | 2016-05-20 | $33.07 | $3.3M | +10.4% | +3.4% | -11.1% |
| XLRN | SELL | 2016-05-18 | 2016-05-20 | $33.04 | $1.2M | +10.4% | +3.4% | -11.1% |
| XLRN | SELL · 10b5-1 | 2015-10-07 | 2015-10-09 | $24.38 | $463K | -30.5% | -6.3% | -26.9% |
| XLRN | SELL · 10b5-1 | 2015-09-08 | 2015-09-10 | $30.20 | $574K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-08-10 | 2015-08-12 | $28.53 | $542K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-07-07 | 2015-07-09 | $29.70 | $564K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-06-08 | 2015-06-09 | $32.51 | $618K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-05-11 | 2015-05-13 | $31.80 | $636K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-04-07 | 2015-04-08 | $34.90 | $541K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-03-09 | 2015-03-10 | $40.25 | $805K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-02-09 | 2015-02-11 | $36.65 | $733K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-01-07 | 2015-01-09 | $39.62 | $792K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-12-08 | 2014-12-09 | $43.99 | $880K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-11-12 | 2014-11-14 | $33.04 | $661K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-10-07 | 2014-10-09 | $29.71 | $594K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-08-14 | 2014-08-15 | $29.78 | $521K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-07-07 | 2014-07-09 | $31.74 | $555K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2014-06-09 | 2014-06-11 | $31.65 | $475K | -30.5% | -6.3% | -6.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.